NTLA — Intellia Therapeutics Inc. price, chart and key statistics

Price data

Price

$11.42

YTD price return

+27.03%

YTD total return

+27.03%

Next earnings

Nov 5, 2026

Market cap

1.6B2016-12 471.9M2026-10 1.6B+239.1% over the window

Enterprise value

1.2B

Shares outstanding

140.1M2016-06 36M2026-06 140.1M+289.3% over the window

52W low

$7.95

52W high

$28.25

From 52W high

-59.58%

From 52W low

+43.65%

52W range

17%

Volume

Rel volume

1.51×

30D volume

5.4M

30D $ vol

65.9M

Fundamentals

Sales (ttm)

59.5M2016-12 16.5M2026-06 59.5M+261.1% over the window

Sales/share

$0.422016-12 $0.462026-06 $0.42-7.2% over the window

EPS (ttm)

-$3.352020-12 -$2.402026-06 -$3.35+39.4% over the window

FCF (ttm)

-348.7M2016-12 29.9M2026-06 -348.7M-1264.5% over the window

FCF/share

-$2.492016-12 $0.832026-06 -$2.49-399.3% over the window

Book value/share

$5.192016-06 $6.212026-06 $5.19-16.4% over the window

Net margin

-672.16%2016-12 -192.0%2026-06 -672.2%+250.1% over the window

ROE

-54.96%2016-09 -12.1%2026-06 -55.0%+355.6% over the window

ROA

-46.66%2016-09 -8.7%2026-06 -46.7%+434.6% over the window

Current ratio

6.652016-06 14.012026-06 6.65-52.6% over the window

Growth (CAGR, ttm) · 10Y

Sales

+12.59%2025-06-30 → 2026-06-3052.9M → 59.5M (+12.6% total)+3.91%2023-06-30 → 2026-06-3053M → 59.5M (+12.2% total)+7.31%2021-06-30 → 2026-06-3041.8M → 59.5M (+42.3% total)+14.48%2016-12-31 → 2026-06-3016.5M → 59.5M (+261.1% total)

Shares

+30.56%2025-06-30 → 2026-06-30107.3M → 140.1M (+30.5% total)+16.55%2023-06-30 → 2026-06-3088.5M → 140.1M (+58.4% total)+13.78%2021-06-30 → 2026-06-3073.5M → 140.1M (+90.7% total)+14.56%2016-06-30 → 2026-06-3036M → 140.1M (+289.3% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share

-13.77%2025-06-30 → 2026-06-30$0.49 → $0.42 (-13.8% total)-10.85%2023-06-30 → 2026-06-30$0.60 → $0.42 (-29.1% total)-5.68%2021-06-30 → 2026-06-30$0.57 → $0.42 (-25.4% total)-0.78%2016-12-31 → 2026-06-30$0.46 → $0.42 (-7.2% total)

Book value/share

n/a-25.35%2023-06-30 → 2026-06-30$12.49 → $5.19 (-58.4% total)-5.06%2021-06-30 → 2026-06-30$6.73 → $5.19 (-22.9% total)-1.78%2016-06-30 → 2026-06-30$6.21 → $5.19 (-16.4% total)

Price

-54.18%2025-10-16 → 2026-10-16$24.91 → $11.42 (-54.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-27.22%2023-10-16 → 2026-10-16$29.63 → $11.42 (-61.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-38.55%2021-10-15 → 2026-10-16$130.49 → $11.42 (-91.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-1.18%2016-10-14 → 2026-10-16$12.86 → $11.42 (-11.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.

Total return

-54.18%2025-10-16 → 2026-10-16$24.91 → $11.42 (-54.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-27.22%2023-10-16 → 2026-10-16$29.63 → $11.42 (-61.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-38.55%2021-10-15 → 2026-10-16$130.49 → $11.42 (-91.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-1.18%2016-10-14 → 2026-10-16$12.86 → $11.42 (-11.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-3.4×2016-12 -17.932026-10 -4.00-77.7% over the window

Fwd P/E

-5.1×

P/S (ttm)Market cap ÷ TTM revenue.

26.9×2017-03 30.812026-10 26.89-12.7% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

2.2×2016-12 2.162026-10 2.20+1.6% over the window

EV/Sales (ttm)

20.8×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-21.79%2016-12 6.3%2026-06 -14.7%-331.8% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 140.1M ÷ 107.3M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-30.56%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-30.56%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-30.56%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-128.2M) ÷ today's market cap ($1.6B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

-8.01%2016-12 -36.1%2026-06 -5.4%-85.0% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-128.2M + TTM dividends $0) ÷ today's market cap ($1.6B). Same caveat as the cash buyback yield.

-8.01%2016-12 -36.1%2026-06 -5.4%-85.0% over the window

Vs own 10Y history

P/S

33rd

P/B

15th